PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1307786
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1307786
Asia-Pacific drug modeling software market is expected to reach USD 1,999.99 million by 2030 from USD 1,085.16 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2033.
Asia-Pacific Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country (China, Japan , South Korea , India , Australia , Singapore, Thailand , Indonesia , Philippines , Malaysia , New Zealand , Vietnam , Taiwan, Rest Of Asia-Pacific) - Industry Trends and Forecast to 2030.